193 related articles for article (PubMed ID: 35037525)
1. Utilizing RNA nanotechnology to construct negatively charged and ultrasound-responsive nanodroplets for targeted delivery of siRNA.
Guo L; Shi D; Shang M; Sun X; Meng D; Liu X; Zhou X; Li J
Drug Deliv; 2022 Dec; 29(1):316-327. PubMed ID: 35037525
[TBL] [Abstract][Full Text] [Related]
2. pH- and Ultrasound-Responsive Paclitaxel-Loaded Carboxymethyl Chitosan Nanodroplets for Combined Imaging and Synergistic Chemoradiotherapy.
Shang M; Sun X; Guo L; Shi D; Liang P; Meng D; Zhou X; Liu X; Zhao Y; Li J
Int J Nanomedicine; 2020; 15():537-552. PubMed ID: 32021193
[TBL] [Abstract][Full Text] [Related]
3. Ultrasound-mediated nanobubble destruction (UMND) facilitates the delivery of A10-3.2 aptamer targeted and siRNA-loaded cationic nanobubbles for therapy of prostate cancer.
Wu M; Zhao H; Guo L; Wang Y; Song J; Zhao X; Li C; Hao L; Wang D; Tang J
Drug Deliv; 2018 Nov; 25(1):226-240. PubMed ID: 29313393
[TBL] [Abstract][Full Text] [Related]
4. Charge-conversion and ultrasound-responsive O-carboxymethyl chitosan nanodroplets for controlled drug delivery.
Meng D; Guo L; Shi D; Sun X; Shang M; Zhou X; Li J
Nanomedicine (Lond); 2019 Oct; 14(19):2549-2565. PubMed ID: 31271101
[No Abstract] [Full Text] [Related]
5. Systemic Delivery of Anti-miRNA for Suppression of Triple Negative Breast Cancer Utilizing RNA Nanotechnology.
Shu D; Li H; Shu Y; Xiong G; Carson WE; Haque F; Xu R; Guo P
ACS Nano; 2015 Oct; 9(10):9731-40. PubMed ID: 26387848
[TBL] [Abstract][Full Text] [Related]
6. Dual functional RNA nanoparticles containing phi29 motor pRNA and anti-gp120 aptamer for cell-type specific delivery and HIV-1 inhibition.
Zhou J; Shu Y; Guo P; Smith DD; Rossi JJ
Methods; 2011 Jun; 54(2):284-94. PubMed ID: 21256218
[TBL] [Abstract][Full Text] [Related]
7. RNA nanoparticles harboring annexin A2 aptamer can target ovarian cancer for tumor-specific doxorubicin delivery.
Pi F; Zhang H; Li H; Thiviyanathan V; Gorenstein DG; Sood AK; Guo P
Nanomedicine; 2017 Apr; 13(3):1183-1193. PubMed ID: 27890659
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of specific delivery of chimeric phi29 pRNA/siRNA nanoparticles to multiple tumor cells.
Li L; Liu J; Diao Z; Shu D; Guo P; Shen G
Mol Biosyst; 2009 Nov; 5(11):1361-8. PubMed ID: 19823753
[TBL] [Abstract][Full Text] [Related]
9. Assembly of multifunctional phi29 pRNA nanoparticles for specific delivery of siRNA and other therapeutics to targeted cells.
Shu Y; Cinier M; Shu D; Guo P
Methods; 2011 Jun; 54(2):204-14. PubMed ID: 21320601
[TBL] [Abstract][Full Text] [Related]
10. Novel ultrasound-responsive chitosan/perfluorohexane nanodroplets for image-guided smart delivery of an anticancer agent: Curcumin.
Baghbani F; Chegeni M; Moztarzadeh F; Hadian-Ghazvini S; Raz M
Mater Sci Eng C Mater Biol Appl; 2017 May; 74():186-193. PubMed ID: 28254284
[TBL] [Abstract][Full Text] [Related]
11. RNA nanoparticle as a vector for targeted siRNA delivery into glioblastoma mouse model.
Lee TJ; Haque F; Shu D; Yoo JY; Li H; Yokel RA; Horbinski C; Kim TH; Kim SH; Kwon CH; Nakano I; Kaur B; Guo P; Croce CM
Oncotarget; 2015 Jun; 6(17):14766-76. PubMed ID: 25885522
[TBL] [Abstract][Full Text] [Related]
12. Paclitaxel-loaded and A10-3.2 aptamer-targeted poly(lactide-
Wu M; Wang Y; Wang Y; Zhang M; Luo Y; Tang J; Wang Z; Wang D; Hao L; Wang Z
Int J Nanomedicine; 2017; 12():5313-5330. PubMed ID: 28794625
[TBL] [Abstract][Full Text] [Related]
13. Crystal structure of 3WJ core revealing divalent ion-promoted thermostability and assembly of the Phi29 hexameric motor pRNA.
Zhang H; Endrizzi JA; Shu Y; Haque F; Sauter C; Shlyakhtenko LS; Lyubchenko Y; Guo P; Chi YI
RNA; 2013 Sep; 19(9):1226-37. PubMed ID: 23884902
[TBL] [Abstract][Full Text] [Related]
14. Anti-Mucin1 Aptamer-Conjugated Chitosan Nanoparticles for Targeted Co-Delivery of Docetaxel and IGF-1R siRNA to SKBR3 Metastatic Breast Cancer Cells.
Jafari R; Majidi Zolbanin N; Majidi J; Atyabi F; Yousefi M; Jadidi-Niaragh F; Aghebati-Maleki L; Shanehbandi D; Soltani Zangbar MS; Rafatpanah H
Iran Biomed J; 2019 Jan; 23(1):21-33. PubMed ID: 30041514
[TBL] [Abstract][Full Text] [Related]
15. Specific delivery of delta-5-desaturase siRNA via RNA nanoparticles supplemented with dihomo-γ-linolenic acid for colon cancer suppression.
Xu Y; Pang L; Wang H; Xu C; Shah H; Guo P; Shu D; Qian SY
Redox Biol; 2019 Feb; 21():101085. PubMed ID: 30584980
[TBL] [Abstract][Full Text] [Related]
16. Small interfering RNA-loaded chitosan hydrochloride/carboxymethyl chitosan nanoparticles for ultrasound-triggered release to hamper colorectal cancer growth in vitro.
Yan L; Gao S; Shui S; Liu S; Qu H; Liu C; Zheng L
Int J Biol Macromol; 2020 Nov; 162():1303-1310. PubMed ID: 32603733
[TBL] [Abstract][Full Text] [Related]
17. Carboxymethyl-hexanoyl Chitosan Nanodroplets for Ultrasonic Imaging and Drug Delivery to Tumor.
Jinsui Y; Bing S; Muhua L; Yue L; Jianyi L; Meng D; Kuan C; Chaopin Y; Hui Z; Zhiyi C
Curr Pharm Des; 2018; 24(15):1682-1688. PubMed ID: 29766795
[TBL] [Abstract][Full Text] [Related]
18. Using Planar Phi29 pRNA Three-Way Junction to Control Size and Shape of RNA Nanoparticles for Biodistribution Profiling in Mice.
Haque F; Xu C; Jasinski DL; Li H; Guo P
Methods Mol Biol; 2017; 1632():359-380. PubMed ID: 28730451
[TBL] [Abstract][Full Text] [Related]
19. pH-Sensitive carboxymethyl chitosan-modified cationic liposomes for sorafenib and siRNA co-delivery.
Yao Y; Su Z; Liang Y; Zhang N
Int J Nanomedicine; 2015; 10():6185-97. PubMed ID: 26491291
[TBL] [Abstract][Full Text] [Related]
20. Development of a carrier system containing hyaluronic acid and protamine for siRNA delivery in the treatment of melanoma.
Yang J; Zhao R; Feng Q; Zhuo X; Wang R
Invest New Drugs; 2021 Feb; 39(1):66-76. PubMed ID: 32794135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
